6533b85ffe1ef96bd12c1aa1
RESEARCH PRODUCT
First-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antibody, in patients with advanced gastroesophageal cancer
Ö. TüreciChristoph HuberM. UtschMartin SchulerA. KrilovaS. BauerUgur Sahinsubject
Gastroesophageal cancerOncologybusiness.industrymedicine.drug_classCancer researchMedicineIn patientHuman studyHematologyClaudinbusinessMonoclonal antibodyIMAB362year | journal | country | edition | language |
---|---|---|---|---|
2017-09-01 | Annals of Oncology |